Bruton's tyrosine kinase (Btk) binds to phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P 3 ) through the Btk pleckstrin homology (PH) domain, an interaction thought to be required for Btk membrane translocation during B cell receptor signaling. Here, we report that interaction of PtdIns-3,4,5-P 3 with the PH domain of Btk directly induces Btk enzymatic activation in an in vitro kinase assay. A point mutation that reduces interaction of PtdIns-3,4,5-P 3 with the Btk PH domain blocks in vitro PtdIns-3,4,5-P 3 -dependent Btk activation, whereas the PH domain deletion enhances Btk basal activity but eliminates the PtdIns-3,4,5-P 3 -dependent stimulation. Btk kinase activity and the Btk activation loop phosphorylation site are both required for the PtdIns-3,4,5-P 3 -mediated stimulation of Btk kinase activity. Together, these results suggest that the Btk PH domain is positioned such that it normally suppresses both Btk kinase activity and access to substrates; when interacting with PtdIns-3,4,5-P 3 , this suppression is relieved, producing apparent Btk activation. In addition, using Src family kinase inhibitors and Btk catalytically inactive mutants, we demonstrate that in vivo, the activation of Btk is due to both Lyn phosphorylation and PtdIns-3,4,5-P 3 -mediated direct activation. Thus, the Btk-PtdIns-3,4,5-P 3 interaction serves to translocate Btk to the membrane and directly regulate its signaling function.
The B cell antigen receptor (BCR) 1 produces an inositol-1,4,5-trisphosphate (IP 3 )-mediated calcium signal that is required for antigen-driven B cell development (1, 2) . One of the most important components of this BCR calcium signaling pathway is mediated by Bruton's tyrosine kinase (Btk), the predominant member of the Tec kinase family that is expressed in B cells (3) . Btk is required for the majority of BCR-stimulated IP 3 production, and its function in this process is tightly linked to the accumulation of phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P 3 ) (4 -6). The critical role of Btk/ PtdIns-3,4,5-P 3 -dependent IP 3 production in the B cell receptor signal is demonstrated by the ability of targeted deletions of Btk, the p85 subunit of phosphatidylinositol 3-kinase or phospholipase C␥2, to produce highly similar B cell immunodeficiencies in the mouse (7) (8) (9) (10) (11) and by the association of Btk mutations that abrogates phospholipase C␥2 activation with X-linked agammaglobulinemia in humans (12, 13) . Furthermore, Btk/PtdIns-3,4,5-P 3 -dependent IP 3 signaling is blocked by the Fc␥RIIb1 inhibitory receptor, whose coengagement with the BCR has been shown to inhibit BCR-mediated IP 3 production, BCR-mediated calcium signaling, BCR-dependent antibody production, and B cell proliferation (14) .
The Btk recruitment into activated BCR signaling complexes is thought to be a direct result of its interaction with PtdIns-3,4,5-P 3 in the plasma membrane following local accumulation after BCR engagement (4, 5) . This model of Btk activation is based on evidence from direct binding of the Btk PH domain and PtdIns-3,4,5-P 3 in vitro (15, 16) and by phosphatidylinositol 3-kinase-dependent membrane translocation of the Btk PH domain fused to green fluorescent protein (15) (16) (17) . After binding to PtdIns-3,4,5-P 3 , Btk then becomes activated via transphosphorylation through Src family kinase-dependent mechanisms and autophosphorylation of its kinase domain activation loop tyrosine (18) . However, whether Btk activation also might be directly regulated by the Btk PH domain/PtdIns-3,4,5-P 3 interaction has not been addressed. Here, we have investigated this question using an in vitro Btk kinase assay. Our data show that PtdIns-3,4,5-P 3 is able to directly induce Btk enzymatic activity in vitro and, therefore, support a dual role for PtdIns-3,4,5-P 3 in the activation of Btk signaling function, namely membrane translocation in proximity to activated B cell receptor complexes and direct regulation of Btk kinase domain signaling function.
EXPERIMENTAL PROCEDURES
Cell Culture, Recombinant Virus Production and cDNAs-A20 mouse B cells and Ramos human B cells were grown in RPMI 1640 with 10% fetal bovine serum and 10 Ϫ5 M 2-mercaptoethanol. NIH3T3 cells were grown in RPMI 1640 with 10% calf serum. A20 infections were performed by adding 5 plaque-forming unit/cell of recombinant virus to ϳ20% confluent A20 cells and allowing infections to proceed for 12-15 h. Where appropriate, control recombinant virus was added so that all samples were exposed to an equal number of plaque-forming unit/cell. A recombinant virus containing a cDNA-encoding human G␤l inserted in an antisense orientation was used as the control virus because the transcript generated was similar in length to that of Btk.
The pSC-FLAG4 vector was constructed by ligating the FLAG epitope coding sequence and the following multienzyme restriction site sequence (GTCGATTGGCCGCCACCATGGGCGACTACAAGGACGA-CGATGACAAGGCGGCCGCGGTACCACTAGTGCATGCGTCGACCC-CGGG) into the pSC-66 vaccinia recombination plasmid using 5ЈSalI and 3ЈXbaI restriction sites.
The FLAG-tagged wild type and mutant forms of Btk were constructed by subcloning the wild type (nucleotides , ⌬PH (nucleotides 400 -1977), ⌬kinase (nucleotides 1-1182) cDNA into the pSC-FLAG4 plasmid using 5ЈNotI and 3ЈKpnI restriction sites. Recombinant viruses were then selected with 5-bromo-2Ј-deoxyuridine/␤-galactosid-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ‡ Current address: Dept. of Pediatrics, Univ. of Washington, Seattle, WA 98195-6320.
§ To whom correspondence should be addressed. Tel.: 617-667-1324; Fax: 617-667-1323; E-mail: jkinet@caregroup.harvard.edu. 1 The abbreviations used are: BCR, B cell antigen receptor; IP 3 , inositol-1,4,5-trisphosphate; PtdIns-3,4,5-P 3 , phosphatidylinositol-3,4,5-trisphosphate; PH, pleckstrin homology; PS, phosphatidylserine; PtdIns-4,5-P 2 , phosphatidylinositol-4,5-bisphosphate; PDK1, 3-phosphoinositidedependent kinase 1. ase selection, amplified, and titered using standard techniques (19) . Other recombinant Btk and vaccinia viruses have been described previously (4, 6, 18) .
Pharmacologic Reagents, Antibodies, Cell Lysis, Immunoprecipitations, and Western Blotting-Phosphatidylserine (PS) was purchased from Avanti Polar. Lipids, phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P 2 ), and PtdIns-3,4,5-P 3 were purchased from Biomol. PP2 was purchased from Calbiochem. The enolase substrate was purchased from Sigma. Anti-FLAG M2 antibody was obtained from Sigma. Antiphosphotyrosine antibody 4G10 was obtained from Upstate Biotechnology. Polyclonal anti-Btk has been described previously (18) . Stimulation of A20 B cells was performed with F(abЈ) 2 rabbit anti-mouse IgG (15 g/ml) purchased from Jackson Immunoresearch.
Cells were lysed in Tris-HCl-buffered saline (pH 7.4) containing 1% Brij 97 or 0.5% Triton X-100, 2 mM sodium vanadate, 5 mM EDTA, 5 mM sodium fluoride, and 5 g/ml of leupeptin and pepstatin. Immunoprecipitations, Western transfer, and immunoblotting were described previously (20) . The precipitates were subjected to Western blot analysis using enhanced chemifluorescent detection system (Amersham Pharmacia Biotech). The blots were analyzed using a Molecular Dynamics STORM imager and ImageQuant software.
Stimulation by Lipids and in Vitro Kinase Assays-In vitro kinase assay was carried out utilizing previously described standard protein kinase C vesicle assay (21) . Briefly, mixed vesicles containing PS, PtdIns-4,5-P 2, or PtdIns-3,4,5-P 3 were sonicated on ice for 10 min in 10 mM Hepes, pH 7. min. Reactions were stopped by addition of 2ϫ SDS-polyacrylamide gel electrophoresis sample buffer and heating to 100°C for 5 min. Proteins were separated by 8% SDS-polyacrylamide gel electrophoresis. After electrophoresis the gels were stained with Coomassie Blue. Autoradiograms of the gels were obtained with an overnight exposure to a storage phosphor screen and measurement of incorporated radioactivity using a Molecular Dynamics STORM imager and ImageQuant software. For some experiments, the bands of Btk and enolase were excised, and the incorporated radioactivity was measured by liquid scintillation counter.
Quantification and Calculation of the Stimulation and Phosphorylation Indexes-The volume of the bands was measured using ImageQuant software (Molecular Dynamics). The stimulation index and tyrosine phosphorylation index were determined by comparing the density rations of the bands to those of the base-line sample and using the formula: stimulation index ϭ (density of phosphorylation band/ density of Btk protein band) test sample :(density of phosphorylation band/ density of Btk protein band) base-line control sample , tyrosine phosphorylation index ϭ (density of tyrosine phosphorylation band/density of Btk protein band) test sample :(density of tyrosine phosphorylation band/density of Btk protein band) base-line control sample . 3 Induces Btk Phosphorylation-To analyze whether interactions between PtdIns-3,4,5-P 3 and the Btk PH domain might regulate Btk function, we first examined whether the presence of PtdIns-3,4,5-P 3 might be able to affect Btk in vitro kinase activity in recombinant Btk immunoprecipitates or add to lysates from cells overexpressing Btk. Fig. 1A shows that the presence of PtdIns-3,4,5-P 3 significantly in- Upper panel, cells were harvested, washed once with calcium buffer (135 mM NaCl, 10 mM KCl, 10 mM Hepes (pH 7.5), 5.6 mM glucose, 0.1% bovine serum albumin, 1 mM MgCl 2 , 1 mM CaCl 2 ), lysed, and then postnuclear supernatants were immunoprecipitated with anti-FLAG antibody. Precipitates were divided into three aliquots and treated with mixed lipids containing phosphatidylserine 200 M alone (PS), PS 100 M and PtdIns-4,5-P 2 100 M (PS/PIP2), or PS 100 M and PtdIns-3,4,5-P 3 100 M (PS/PIP3). The precipitates were then subjected to an in vitro kinase assay. Bottom panel, cells were harvested, washed once with calcium buffer, resuspended at 10 7 cells/ml in calcium buffer, and stimulated or not stimulated for 2 min with 30 g/ml F(abЈ) 2 rabbit anti-mouse IgG. Cells were quickly centrifuged and lysed, and postnuclear supernatants were incubated with and without PtdIns-3,4,5-P 3 100 M for 5 min at room temperature. Lysates were then subjected to SDS-polyacrylamide gel electrophoresis and analyzed by Western blotting with the indicated antibody. B, PtdIns-3,4,5-P 3 activates in vitro kinase activity of Btk expressed in a non-hematopoietic cell context. Next, to eliminate the potential contribution of other B cellspecific signaling pathways, such as through the endogenous Lyn as well as through other hematopoietic phosphatases, we examined Btk produced in a non-hematopoietic cell line (Fig.  1B) . As little as 1 M PtdIns-3,4,5-P 3 significantly activated Btk produced in NIH3T3 cells compared with PtdIns-3,4-P 2 or Fig. 1A . B-D, analysis of various Btk mutants. NIH3T3 fibroblasts were infected for 3 h with the indicated vaccinia viruses, harvested, and lysed, and postnuclear supernatants were immunoprecipitated with the indicated antibody or analyzed directly. Top panels, precipitates were divided in two aliquots, treated or untreated with PtdIns-3,4,5-P 3 , and analyzed for in vitro kinase activity as in Fig. 1 . Bottom panels, whole cell lysates were analyzed by Western blotting using the indicated antibody. In vitro kinase activities of Btk mutants were representative from three sets of different experiments. Stimulation indexes (SI) were calculated as described under "Experimental Procedures." From the calculation of 32 P incorporation, ⌬PH mutant showed 4.0 -4.3-fold comparison to the basal level of in vitro kinase activity of wild type Btk. The basal level of in vitro kinase activity of R28C mutant was reduced by 50 -90% of the wild type. No PS alone. We also observed the same activation of endogenous Btk in the human B cell line (Fig. 1C) .
RESULTS
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Furthermore, we observed the enhanced kinase activity of Btk by PtdIns-3,4,5-P 3 toward acid-denatured enolase used here as a substrate (Fig. 1D) .
We then examined the dose/response relationship of PtdIns-3,4,5-P 3 -dependent activation of Btk in vitro by measuring the phosphorylation of Btk and acid-denatured enolase (Fig. 2) . The activation of Btk by various amounts of PtdIns-3,4,5-P 3 was studied in the presence of PS to maintain a constant total lipid concentration (200 M). The activation of Btk was observed at concentrations of 10 nM to 10 M, thus yielding a 50% maximal activation (EC 50 ) of ϳ100 nM. This result closely corresponds to the value reported by others for the affinity of the Btk PH domain for PtdIns-3,4,5-P 3 (100 -700 nM) and is consistent with a direct interaction between PtdIns-3,4,5-P 3 and the Btk PH domain being involved in the kinase activation effect (16, 22) .
PtdIns-3,4,5-P 3 -Dependent Phosphorylation of Btk Is Due to Autophosphorylation-To discriminate between autophosphorylation of Btk versus the presence of contaminating kinases such as endogenous Lyn or other Src family kinases, we first compared the effect of the Src family-specific inhibitor, PP2, to the enhanced phosphorylation of Btk by PtdIns-3,4,5-P 3 . Even at a concentration of 10 M, PP2 did not affect the enhanced phosphorylation (Fig. 3A) . (Note that we will show in Fig. 4 , A and B that 10 M PP2 inhibits Lyn activity efficiently but not Btk).
We then analyzed two different inactive versions of Btk (a kinase domain deletion mutant and the K430R ATP binding site mutant) (see Fig. 3, B and C) . Neither of these mutants demonstrated any apparent kinase activity (either basal or PtdIns-3,4,5-P 3 -dependent) in the in vitro assay conditions. These data demonstrate unequivocally that the kinase activity observed in these assays is entirely due to the autophosphorylation kinase activity of Btk.
The Btk PH Domain Allosterically Regulates Btk Activation in Vitro-To analyze further the mechanism through which PtdIns-3,4,5-P 3 produced Btk activation in our assay, we examined whether PtdIns-3,4,5-P 3 would be able to activate various other mutant versions of Btk in a series of separate experiments (Fig. 3, B-D) . We analyzed a PH deletion mutant of Btk, the R28C PH domain mutant with known reduced affinity for PtdIns-3,4,5-P 3 , and the Y551F activation loop mutant (Y551F). All three mutants revealed a lack of PtdIns-3,4,5-P 3 -stimulated activity. However, the R28C and Y551F mutants showed normal levels of basal activity whereas the PH domain deletion mutant had a highly elevated basal activity, which was the same as or greater than the PtdIns-3,4,5-P 3-stimulated activity of wild type Btk (compare lanes 2, 3, and 4 of the top panel). Together, these results suggest that the PH domain is normally positioned so that it suppresses Btk kinase activity in this assay and that PtdIns-3,4,5-P 3 relieves this suppression when it is available to bind to the PH domain of Btk.
An interesting additional question elucidated by our findings is whether a PH domain deletion mutant would be able to signal normally given that it is fully active in vitro and its SH2 domain, which is thought to mediate interaction with specific target substrates, would be expected to retain normal binding activity (25) . We therefore compared the effect of Btk ⌬PH overexpression to that of wild type Btk through BCR calcium signaling and IP3 assays in the A20 B cell line. The Btk ⌬PH mutant produced no enhancement in either the BCR calcium signal or IP 3 production in A20 B cell in conditions when wild type Btk does produce enhancements in both (data not shown). These data suggest that the PH domain membrane targeting is required also for proper integration of Btk into the BCR signaling complex, although we cannot exclude that PH domain deletion alters the folding/conformation of the remaining Btk domains in an idiosyncratic manner that prohibits normal Btk signaling function.
At Least Half of Btk Is Autophosphorylated by the Interaction of PtdIns-3,4,5-P 3 in Vivo-
The above results showed direct interaction of PtdIns-3,4,5-P 3 with the Btk PH domain with an enhancement of the kinase activity of Btk. On the other hand, we and others have described that Btk is also activated by the transphosphorylation of Src family kinase, Lyn, in B cells. Indeed, Btk is activated by both interaction of PtdIns-3,4,5-P 3 and by transphosphorylation with Lyn. How significant is the autophosphorylation of Btk by the interaction of PtdIns-3,4,5-P 3 while transphosphorylated by Lyn? To answer this question, we examined the tyrosine phosphorylation of Btk in A20 B cells with the overexpression of the constitutively active form of phosphatidylinositol 3-kinase, P110␣, using PP2 and the K430R Btk to eliminate each one of the phosphorylation pathways. As seen in Fig. 4 , incubation of A20 cells with 10 M PP2 did not affect the kinase activity of Btk (Fig. 4A) , whereas it significantly inhibited the kinase activity of Lyn (Fig. 4B) . The tyrosine phosphorylation of wild type Btk in PP2-treated cells was half that found in PP2-untreated cells; whereas in the K430R mutants, tyrosine phosphorylation of Btk was equivalent to that of wild type Btk in PP2-treated cells. These data suggest that in vivo, at least half of the Btk is autophosphorylated by PtdIns-3,4,5-P 3 (Fig. 4C) . DISCUSSION We have presented biochemical evidence that the interaction between PtdIns-3,4,5-P 3 and the Btk PH domain directly regulates the catalytic activity of Btk. This conclusion is based on the following results: the stimulation of the in vitro activity of wild type Btk by PtdIns-3,4,5-P 3 , the disruption of this effect either by a PH domain mutation (R28C) known to eliminate its PtdIns-3,4,5-P 3 binding activity or by deletion of the Btk PH domain, and the observation of enhanced basal activity in our Btk PH domain deletion mutant. Together, these findings suggest that the Btk PH domain normally acts to suppress Btk kinase activity and that this domain may in addition hinder access of the kinase domain to substrates. In either case, interaction with PtdIns-3,4,5-P 3 or PH domain deletion relieves the inhibition, producing a form of Btk that is now able to more effectively autophosphorylate and transphosphorylate substrates.
We and others have previously noted significant similarity between the role of PtdIns-3,4,5-P 3 in Btk activation and that proposed for D-3-phosphoinositides in regulation of the serinethreonine kinase, Akt/protein kinase B (Fig. 5) (5, 23) . Full activation of wild type Akt requires phosphorylation on its activation loop (24) . This phosphorylation occurs only in the presence of D-3-phosphoinositides. D-3-Phosphoinositides fail to promote the 3-phosphoinositide-dependent kinase 1 (PDK1)-mediated phosphorylation of a phosphoinositide-binding PHdeficient Akt mutant (R25C) and deletion of the Akt PH domain allows the Akt ⌬PH molecule to be phosphorylated by PDK1 in the absence of phosphoinositides in vitro. These findings have led to the proposal that the Akt PH domain acts as an inhibitor of PDK1-dependent phosphorylation of Akt activation loop residues required for full activation and that D-3-phosphoinositide binding to the PH domain relieves these inhibitory effects (Fig. 5A) . In contrast, the Btk activation mechanism has been proposed to consist of membrane targeting by the binding of PtdIns-3,4,5-P 3 to the Btk PH domain. Then, tyrosine phosphorylation of its activation loop occurs through Src family kinase, Lyn-dependent transphosphorylation and Btk autophosphorylation (Fig. 5B ). Our data demonstrate that enhanced PtdIns-3,4,5-P 3 -dependent Btk autophosphorylation is blocked in the Btk-Y551F activation loop mutant. This latter result demonstrates that this PtdIns-3,4,5-P 3 -dependent Btk autophosphorylation primarily occurs at the activation loop tyrosine. This result is consistent with previous data (18) and, in conjunction with the Btk PH domain mutant data, suggests that in this "opened" form of Btk the activation tyrosine Y551 is more accessible to both Lyn and Btk. (Fig. 5B) . Modification of our previous Btk activation model, in light of these data, suggests that PtdIns-3,4,5-P 3 -mediated regulation of Btk resembles the model proposed for D-3-phosphoinositide-mediated regulation of Akt. In conclusion, together with previous data, our results suggest that PtdIns-3,4,5-P 3 plays dual and probably functionally inseparable roles in the activation of PH-containing Tec family kinases; it provides proximity to target effector molecules (by targeting the kinase to the plasma membrane) as well as an activated and more accessible kinase domain (by opening up the kinase as suggested in this paper). These data suggest a modified model of Btk activation, which is similar to one previously proposed for the D-3-phosphoinositide-regulated serinethreonine kinase, Akt, in which D-3-phosphoinositides also played a dual localization and allosteric regulatory role. Such a mechanism is theoretically attractive for the control of signaling molecules like Tec kinases and Akt whose functions are closely linked to cell fate decisions as it provides a high level of assurance that their signaling function is directed toward the proper targets in the proper context.
